Medtronic lands Euro win for next-gen heart implants

February 4, 2013 by MassDevice staff

Medical device company Medtronic wins CE Mark approval in the European Union for its next-generation family of Evera implantable cardioverter-defibrillators.

Medtronic logo

Medtronic (NYSE:MDT) touted CE Mark approval in the European Union for its next-generation Evera portfolio of implantable cardioverter-defibrillators.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp